Medical devices, healthcare technology and the business of care
510(k) clearance · K260525

NextMR Spine

MRI2CT, Inc. · Decision date Sep 4, 2026

MEDTECHLEDGER EXPLANATIONK260525

What did the FDA decide?

MRI2CT, Inc. received a substantially equivalent (SESE) decision for NextMR Spine on September 4, 2026, under 510(k) number K260525. The submission was received February 17, 2026, and reviewed in the Radiology panel under 21 CFR 892.2050, product code QIH, Class II. The device is described as software-only, cloud-based MRI image enhancement that generates DICOM series for visualizing spinal bony anatomy in the lumbar vertebrae (L1–L5) and sacrum in patients 18 and older.

The listed predicate is BoneMRI (MRIguidance B.V., K233030), also product code QIH. The summary characterizes NextMR Spine's anatomical scope as narrower and its age range as more conservative than the predicate, and states the device is not intended to replace CT in general or for tumor diagnosis or monitoring. SESE denotes 510(k) clearance, not PMA approval. The summary's performance claims are not independently verified here, and the reviewed clinical evidence and numerical results are not available in the provided excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 4, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260525
Regulatory pathway
510(k) premarket notification
Applicant
MRI2CT, Inc.
Product code
QIH
Decision code
SESE
Decision date
Sep 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Applicant
MRI2CT, Inc.
Product code
QIH
FDA device class
2

FDA decision timeline

  1. K260525 received

    Application receipt date recorded by FDA.

  2. K260525 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
Peek Health, S.A.510(k) clearanceNov 4, 2026FDA
AVICENNA.AI510(k) clearanceOct 19, 2026FDA
UAB Ligence510(k) clearanceOct 7, 2026FDA
NeuroDRK262134
Deep Reasoning Ai, Inc.510(k) clearanceOct 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

MRI2CT, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Claymont, DE

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records